Published March 2018 | Version v1
Journal article Metadata-only

Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer

Creators

  • 1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (United States)
  • 2. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (United States)

Description

BackgroundWe evaluated pretreatment total lymphocyte count (TLC, marker of immunosuppression), neutrophil-to-lymphocyte ratio (NLR, marker of inflammation), and overall survival (OS) in patients with extensive-stage small-cell lung cancer (ES-SCLC).

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2017.12.030

Additional details

Identifiers

DOI
10.1016/j.radonc.2017.12.030;
PII
S016781401830015X;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
126
Journal Issue
3
Journal Page Range
p. 499-505
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51004963
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
IMMUNOSUPPRESSION; INFLAMMATION; LUNGS; LYMPHOCYTES; NEOPLASMS; NEUTROPHILS; PATIENTS
Descriptors DEC
ANIMAL CELLS; BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY; BODY FLUIDS; CONNECTIVE TISSUE CELLS; DISEASES; LEUKOCYTES; MATERIALS; ORGANS; PATHOLOGICAL CHANGES; RESPIRATORY SYSTEM; SOMATIC CELLS; SYMPTOMS

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.